Labcorp Holdings Inc.

NYSE:LH

Medical - Diagnostics & Research

Healthcare
$370.78 -1.33%

-$3.46 today

Market cap
$30.11B
Beta
0.88
P/E (TTM)
22.4
EPS (TTM)
$11.44
Dividend yield
1.12%
52W Low $241.81High $293.72

Volume 0.69M

Average 0.63M

LH Other Financing Activities

Financing cash flows not reported separately.

Labcorp Holdings Inc.NYSE: LH

Other Financing Activities · Q2 FY2026 · quarter ended Jun 2026

Other financing activities turns negative

Q2 FY2026 other financing activities was -$34.3M, compared with $57.3M a year earlier. Trailing-twelve-month other financing activities was -$311.8M.

Context

  • Other financing activities amounted to 0.3% of revenue in FY2025, down 1.8 pp from a year earlier.
  • Other financing activities increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly other financing activities holds near -$34.3M or moves back toward the trailing-twelve-month quarterly average of -$77.95M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$34.3M-20.6% QoQ
Last fiscal yearDec 2025
-$45.6M-116.7% YoY
LTMJun 2026
-$311.8M-157.1% YoY
Other Financing Activities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-159.9%——
1 year-116.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Financing Activities history

USD · from the cash flow

Latest · FY2025
(45.6M) USD
Year-over-year change
-116.7%

Other Financing Activities vs competitors

How LH compares with its peers on the latest reported figures

  • LH's LTM Jun 2026 other financing activities of $311.8M is the 4th largest of the 7 companies compared; the peer median is $138.48M.
  • Its year-over-year change of -157.1% is the lowest of 5, against a peer median of +719.7%.
  • Other financing activities amounts to 2.2% of revenue for LH, versus a peer median of 7.4%.
LH Competitors Peer median
Other Financing Activities for LH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TMOThermo Fisher Scientific Inc.LTM Sep 2026$4.77B +1086.5%—10.1%
DGXQuest Diagnostics IncorporatedLTM Sep 2026$552M +573.2%+53.9%4.7%
GRALGRAIL, Inc.LTM Jun 2026$423.32M ——256.1%
LHLabcorp Holdings Inc.LTM Jun 2026$311.8M -157.1%—2.2%
GHGuardant Health, Inc.LTM Sep 2026$282.06M +866.3%-30.2%22.1%
QGENQiagen N.V.LTM Jun 2026$21.52M -104.5%—1.0%
NTRANatera, Inc.LTM Jun 2026$5.1M ——0.2%
Peer median (excluding LH) $138.48M+719.7%+11.8%7.4%

Competitors are the stored peer set for LH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income2.38B1B379.2M746M877.7M
Depreciation & Amortization577M537.2M577.3M643.5M681.1M
Deferred Income Tax(37.3M)26.3M(78.1M)(20.1M)97.6M
Stock-Based Compensation132.9M116.8M128.7M116.7M125.8M
Change in Working Capital(263.7M)(603.4M)(361.9M)(154.1M)(526.1M)
Accounts Receivables222M15.9M(75.3M)98.5M(122.2M)
Inventory2.8M(45.5M)(700K)(14.6M)(30.2M)
Accounts Payables(10.2M)307.1M(42.4M)210.3M(52.8M)
Other Working Capital(478.3M)(880.9M)(243.5M)(448.3M)(320.9M)
Other Non-Cash Items321.2M875.5M682.5M253.8M384.4M
Operating Cash Flow3.11B1.96B1.33B1.59B1.64B
Capital Expenditures(460.4M)(481.9M)(453.6M)(489.9M)(434.5M)
Acquisitions (Net)(496.9M)(1.16B)(671.5M)(823.9M)(582M)
Purchases of Investments(27.8M)(17.4M)(29M)(55M)(192.4M)
Sales of Investments13.2M8.1M6.7M06.9M
Other Investing Activities87.3M1.4M(24.1M)2M8M
Investing Cash Flow(884.6M)(1.65B)(1.17B)(1.37B)(1.19B)
Debt Repayment(375M)0(300M)1B(775M)
Common Stock Issued51.7M50.6M0054.3M
Common Stock Repurchased(1.67B)(1.15B)(1.04B)(250.1M)(450M)
Dividends Paid0(195.2M)(254M)(243.1M)(240.7M)
Other Financing Activities(74M)23.6M1.53B273.1M(45.6M)
Financing Cash Flow(2.07B)(1.32B)(59.3M)779.9M(1.46B)
Effect of Forex Changes(7.3M)(24.2M)9.9M(17M)24.1M
Net Change in Cash151.9M(1.04B)106.8M981.9M(986.4M)
Free Cash Flow2.65B1.47B874.1M1.1B1.21B

Labcorp Holdings Inc.

NYSE:LH

Intrinsic Alpha fair value

Locked

Current Price

$370.78

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.